Moderna’s stock stumbles on report HHS is reviewing $590 million award for bird-flu vaccine

Moderna’s stock stumbles on report HHS is reviewing $590 million award for bird-flu vaccine

Source: MarketWatch | Published: February 27, 2025, 5:08 p.m.

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

Read Original Article Back to News List

Related News

Money talks with your parents are tough. Here’s how and why you need to have them.

6 hours, 42 minutes ago

Some Americans are stockpiling $220 sneakers before Trump’s tariffs raise prices even higher

7 hours, 46 minutes ago

Golfers think the sport keeps them healthy. New research says it will even help them live longer.

10 hours, 49 minutes ago

Financial skills slip as we age. Here’s how we can learn to stay sharp.

1 day, 1 hour ago

Federal judge makes your Social Security data harder for DOGE to access — for now

1 day, 3 hours ago